Mesenchymal Stem Cells: Potential Application in Intervertebral Disc Regeneration

Overview

Journal Transl Pediatr

Publisher AME Publishing Company

Specialty Pediatrics

Date 2016 Feb 3

PMID 26835326

Citations 21

Authors

Aiqun Wei

Bojiang Shen

Lisa Williams

Ashish Diwan

Affiliations

Soon will be listed here.

Abstract

Chronic low back pain is one of the leading public health problems in developed countries. Degeneration of the intervertebral disc (IVD) is a major pathological process implicated in low back pain, which is characterized by cellular apoptosis and senescence with reduced synthesis of extracellular matrix (ECM). Currently, there is no clinical therapy targeting the reversal of disc degeneration. Recent advances in cellular and molecular biology have provided an exciting approach to disc regeneration that focuses on the delivery of viable cells to the degenerative disc. Adult mesenchymal stem cells (MSCs) are multipotent stem cells with self-renewal capacities and are able to differentiate into diverse specialized cell types, including chondrocyte lineages. The potential of stem cell therapy in disc degeneration is to repopulate the disc with viable cells capable of producing the ECM and restoring damaged tissue. The present literature review summarizes recent advances in basic research and clinical trials of MSCs to provide an outline of the key roles of MSCs therapies in disc repair. The review also discusses the controversies, challenges and therapeutic concepts for the future.

Citing Articles

Review of Recent Treatment Strategies for Lumbar Disc Herniation (LDH) Focusing on Nonsurgical and Regenerative Therapies.

Lee J, Lee S, Kang K, Oh S, Chae D J Clin Med. 2025; 14(4).

PMID: 40004728 PMC: 11856164. DOI: 10.3390/jcm14041196.

High impact works on stem cell transplantation in intervertebral disc degeneration.

Chen X, Li H, Huang B, Ruan J, Li X, Li Q BMC Musculoskelet Disord. 2024; 25(1):1029.

PMID: 39702055 PMC: 11660786. DOI: 10.1186/s12891-024-08131-4.

Exosomes Derived from Rejuvenated Stem Cells Inactivate NLRP3 Inflammasome and Pyroptosis of Nucleus Pulposus Cells via the Transfer of Antioxidants.

Peng S, Liu X, Chang L, Liu B, Zhang M, Mao Y Tissue Eng Regen Med. 2024; 21(7):1061-1077.

PMID: 39060654 PMC: 11416441. DOI: 10.1007/s13770-024-00663-z.

The most influential articles on stem cells in intervertebral disc degeneration.

Ye S, Chen R, Shi J, Wu Y BMC Musculoskelet Disord. 2024; 25(1):116.

PMID: 38331829 PMC: 10851499. DOI: 10.1186/s12891-024-07253-z.

Selective cargo sorting in stem cell-derived small extracellular vesicles: impact on therapeutic efficacy for intervertebral disc degeneration.

Liao Z, Tong B, Zhang X, Zhang W, Ke W, Liang H Clin Transl Med. 2023; 13(12):e1494.

PMID: 38037469 PMC: 10689973. DOI: 10.1002/ctm2.1494.

References

Vos T, Flaxman A, Naghavi M, Lozano R, Michaud C, Ezzati M . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. PMC: 6350784. DOI: 10.1016/S0140-6736(12)61729-2. View

Yuan M, Yeung C, Li Y, Diao H, Cheung K, Chan D . Effects of nucleus pulposus cell-derived acellular matrix on the differentiation of mesenchymal stem cells. Biomaterials. 2013; 34(16):3948-3961. DOI: 10.1016/j.biomaterials.2013.02.004. View

Neirinckx V, Coste C, Rogister B, Wislet-Gendebien S . Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play. Stem Cells Transl Med. 2013; 2(4):284-96. PMC: 3659839. DOI: 10.5966/sctm.2012-0147. View

Henriksson H, Thornemo M, Karlsson C, Hagg O, Junevik K, Lindahl A . Identification of cell proliferation zones, progenitor cells and a potential stem cell niche in the intervertebral disc region: a study in four species. Spine (Phila Pa 1976). 2009; 34(21):2278-87. DOI: 10.1097/BRS.0b013e3181a95ad2. View

Haefeli M, Kalberer F, Saegesser D, Nerlich A, Boos N, Paesold G . The course of macroscopic degeneration in the human lumbar intervertebral disc. Spine (Phila Pa 1976). 2006; 31(14):1522-31. DOI: 10.1097/01.brs.0000222032.52336.8e. View

Haque N, Rahman M, Abu Kasim N, Mohammed Alabsi A . Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. ScientificWorldJournal. 2013; 2013:632972. PMC: 3771429. DOI: 10.1155/2013/632972. View

Chen Y, Zhang Y, Zhang W, Luan G, Liu Z, Gao Y . Insights into the hallmarks of human nucleus pulposus cells with particular reference to cell viability, phagocytic potential and long process formation. Int J Med Sci. 2013; 10(13):1805-16. PMC: 3856371. DOI: 10.7150/ijms.6530. View

Borthakur A, Maurer P, Fenty M, Wang C, Berger R, Yoder J . T1ρ magnetic resonance imaging and discography pressure as novel biomarkers for disc degeneration and low back pain. Spine (Phila Pa 1976). 2011; 36(25):2190-6. PMC: 4002043. DOI: 10.1097/BRS.0b013e31820287bf. View

Puetzer J, Petitte J, Loboa E . Comparative review of growth factors for induction of three-dimensional in vitro chondrogenesis in human mesenchymal stem cells isolated from bone marrow and adipose tissue. Tissue Eng Part B Rev. 2010; 16(4):435-44. DOI: 10.1089/ten.TEB.2009.0705. View

10.

Hunter C, Matyas J, Duncan N . The notochordal cell in the nucleus pulposus: a review in the context of tissue engineering. Tissue Eng. 2003; 9(4):667-77. DOI: 10.1089/107632703768247368. View

11.

Baghaban Eslaminejad M, Fani N, Shahhoseini M . Epigenetic regulation of osteogenic and chondrogenic differentiation of mesenchymal stem cells in culture. Cell J. 2013; 15(1):1-10. PMC: 3660019. View

12.

Mern D, Fontana J, Beierfuss A, Thome C, Hegewald A . A combinatorial relative mass value evaluation of endogenous bioactive proteins in three-dimensional cultured nucleus pulposus cells of herniated intervertebral discs: identification of potential target proteins for gene therapeutic approaches. PLoS One. 2013; 8(11):e81467. PMC: 3836971. DOI: 10.1371/journal.pone.0081467. View

13.

Hoyland J, Le Maitre C, Freemont A . Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxford). 2008; 47(6):809-14. DOI: 10.1093/rheumatology/ken056. View

14.

Kim K, Ha K, Lee J, Nam S, Woo Y, Lim T . Notochordal cells stimulate migration of cartilage end plate chondrocytes of the intervertebral disc in in vitro cell migration assays. Spine J. 2008; 9(4):323-9. DOI: 10.1016/j.spinee.2008.05.003. View

15.

Peroglio M, Grad S, Mortisen D, Sprecher C, Illien-Junger S, Alini M . Injectable thermoreversible hyaluronan-based hydrogels for nucleus pulposus cell encapsulation. Eur Spine J. 2011; 21 Suppl 6:S839-49. PMC: 3535207. DOI: 10.1007/s00586-011-1976-2. View

16.

Bae W, Masuda K . Emerging technologies for molecular therapy for intervertebral disk degeneration. Orthop Clin North Am. 2011; 42(4):585-601, ix. PMC: 4029337. DOI: 10.1016/j.ocl.2011.07.004. View

17.

Das R, Jahr H, van Osch G, Farrell E . The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Eng Part B Rev. 2009; 16(2):159-68. DOI: 10.1089/ten.TEB.2009.0296. View

18.

Eskola P, Mannikko M, Samartzis D, Karppinen J . Genome-wide association studies of lumbar disc degeneration--are we there yet?. Spine J. 2013; 14(3):479-82. DOI: 10.1016/j.spinee.2013.07.437. View

19.

Song Y, Karasugi T, Cheung K, Chiba K, Ho D, Miyake A . Lumbar disc degeneration is linked to a carbohydrate sulfotransferase 3 variant. J Clin Invest. 2013; 123(11):4909-17. PMC: 3809787. DOI: 10.1172/JCI69277. View

20.

Seki S, Kawaguchi Y, Chiba K, Mikami Y, Kizawa H, Oya T . A functional SNP in CILP, encoding cartilage intermediate layer protein, is associated with susceptibility to lumbar disc disease. Nat Genet. 2005; 37(6):607-12. DOI: 10.1038/ng1557. View